The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases-Reference-Cited by-同舟云学术

The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases

Published:2004-09 Issue:1 Volume:176 Page:125-132
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Lee Wen Lieng,Sheu Wayne Huey-Herng,Liu Tsun-Jui,Lee Wen-Jen,Tsao Cheng-Rong,Ju Yong-Hua,Liao Mao-Fang,Chen Ying-Tsung,Ting Chih-Tai

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Medical treatment of peripheral arterial disease and claudication;Hiatt;N. Engl. J. Med.,2001

2. Inflammation and atherosclerosis;Libby;Circulation,2002

3. Novel clinical markers of vascular wall inflammation;Blake;Circ. Res.,2001

4. CD40 signaling and plaque instability;Schonbeck;Circ. Res.,2001

5. Adhesion molecules and atherogenesis;Huo;Acta Physiol. Scand.,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial Changes of Serum Calcification Markers and Contralateral Carotid Plaques Echogenicity after Combined Carotid Artery Stenting Plus Intensive Lipid-lowering Therapy in Patients with Bilateral Carotid Stenosis;European Journal of Vascular and Endovascular Surgery;2010-03

2. Peripheral arterial disease and Virchow’s triad;Thrombosis and Haemostasis;2009

3. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels;Clinica Chimica Acta;2008-02

4. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease;Metabolism;2006-08

5. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand;Canadian Journal of Cardiology;2006-06